Director, Informatics and Technology
MOMA Therapeutics, Massachusetts, United States
Having spent seven years in life science software services and then biotechnology leadership roles, Kate understands the varied needs of biotech companies and has learned a thing or two about how high quality data and user-friendly technology enable research discoveries and business intelligence. User success has always been central to her methodology and she is passionate about driving engagement across all levels of an organization, from bench researchers to business leadership.
After consulting with Third Rock Ventures portfolio companies for a year and helping launch companies with integrated and highly adoptable informatics platforms, Kate accepted a full time role at the Boston-based biotech startup MOMA Therapeutics as their head of informatics and technology. Her goal is to be a trusted advisor to both the business and the research sides of the company while deploying and supporting innovative technology solutions that are just as cutting-edge as MOMA’s ambitious research goals. Kate holds a BS in chemistry from Northeastern University and has completed multiple graduate level courses in topics spanning organic and bioanalytical chemistry to executive leadership and management.
Disclosure information not submitted.
Monday, February 7, 2022
10:00 AM – 11:30 AM
Monday, February 7, 2022
10:00 AM – 10:30 AM
Monday, February 7, 2022
4:00 PM – 5:30 PM
Tuesday, February 8, 2022
10:00 AM – 11:30 AM